ArticleJournal of epidemiology and global health2026
Seroprevalence of Toxoplasmosis in France: First Study in 1,995 Blood Donors.
Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The seroprevalence of toxoplasmosis is well-described in French pregnant women, but no data are available in the general population. This study investigated 1,995 blood donors (sex ratio = 1), aged 18 to > 70 years (mean 44.8). The seroprevalence was 50.9% and increased with age, reaching almost 90% in blood donors > 70. Men exhibited a higher seroprevalence than women in age group 30–39 (41.1% vs 27.6%, p = 0.033). Multivariate analysis confirmed that men were more likely to be infected than women (OR = 1.234, p = 0.036). The highest prevalences for Toxoplasma were observed in the Northern and South-Western regions of France (55.2 to 60.5%). The lowest prevalence was observed in the East (41.4%), and was significantly higher in men < 40 years compared to women. These data are consistent with prevalence studies conducted in French pregnant women, but shows for the first time that females are less frequently infected than males, particularly in some regions, which could motivate further epidemiological investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.